Currently Browsing

Our Products

Fenofibric Acid Delayed-Release Capsules 135 mg – 90/Bottle

Overview

Reference Brand:
Trilipix®
Therapeutic Class:
Cardiovascular

Specifications

GCN:
16105
Strength:
135 mg
Size:
90
NDC #:
59651021790
TE Code:
AB

Order Information

Case Qty (min order qty):
24
Case Weight (lbs):
4.766

Attributes

Physical Form:
Capsules
Shape:
Capsules
Color:
Blue/Yellow
Imprint:
"CFB" / "135"
Prescribing Info
Product News

June 09, 2026 | Aurobindo Receives FDA Approval for Cephalexin For Oral Suspension USP, 125 mg/5 mL and 250 mg/5 mL ... Read more

Product News

June 03, 2026 | Aurobindo Receives FDA Approval for Tofacitinib Tablets, 5 mg and 10 mg ... Read more

Product News

June 02, 2026 | Aurobindo Receives FDA Approval for Eluxadoline Tablets, 75 mg and 100 mg ... Read more